Our Investors

Transine has ambitious plans for developing and exploiting the SINEUP® technology across a broad range of applications which are enabled by expert investors, Takeda Ventures, Inc. and the Dementia Discovery Fund.

The Dementia Discovery Fund

The Dementia Discovery Fund (DDF) is a £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.

Takeda Ventures

Takeda Ventures, Inc. focuses on high-calibre therapeutic and platform based, early-stage opportunities around the world. It concentrates on areas aligned with Takeda’s R&D focus including oncology, gastroenterology, neuroscience, and rare disease.


Epidarex is a transatlantic venture capital firm led by a diverse team of early-stage investors building breakthrough life science companies in emerging hubs. We are trusted partners to our founders and co-investors. We use our deep scientific and industry networks to create exceptional value and shared success. Epidarex builds the extraordinary.

Get in Touch

For more information about Transine, please email our team via info@transinetx.com or contact us below.

Contact us